上海博研生物工程研究中心為您現(xiàn)貨提供*的產(chǎn)品與服務(wù)，本中心產(chǎn)品齊全，保證實(shí)驗(yàn)的有效性，提供，是您科研實(shí)驗(yàn)產(chǎn)品的一站式平臺(tái)，咨詢。！

產(chǎn)品名稱：Anti-C9a/C9驚爆優(yōu)惠 補(bǔ)體C9a抗體 

中文名稱：補(bǔ)體C9a抗體
英文名稱：Anti-C9a/C9
產(chǎn)品編號(hào)：BYK-11190R
產(chǎn)品別名：C9a, C9 deficiency; C9 deficiency with dermatomyositis; CO9_HUMAN; Complement component 9; Complement component 9 deficiency; Complement component C9a; Complement component C9a; C9.

本公司另供應(yīng)“補(bǔ)體C9a抗體”的標(biāo)記有：Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.
產(chǎn)品規(guī)格：100ug/200ug
產(chǎn)品濃度： 1mg/1ml
抗體來源：兔源、鼠源、其他
克        隆：單克隆抗體、多克隆抗體
抗體類型：一抗
性        狀： 凍干粉或液體
保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Anti-C9a/C9驚爆優(yōu)惠 補(bǔ)體C9a抗體技術(shù)說明，產(chǎn)品*，由于篇幅原因，更多信息請(qǐng)：

Anti-I3/FITC   熒光素標(biāo)記胰島素受體底物-3抗體IgG
Anti-I4/FITC   熒光素標(biāo)記胰島素受體底物-4抗體IgG
Anti-IRS P53 /FITC  熒光素標(biāo)記胰島素受體底物p53蛋白抗體IgG
Anti-ISR/FITC  熒光素標(biāo)記胰島素受體抗體IgG
Anti-ISR-α /FITC（Insulin Receptor-α）  熒光素標(biāo)記胰島素受體抗體
Anti-JAK1/FITC  熒光素標(biāo)記蛋白質(zhì)*激酶JAK-1抗體IgG
Anti-JAK2/FITC  熒光素標(biāo)記蛋白質(zhì)*激酶JAK-2抗體IgG
Anti-phospho JAK2/FITC  熒光素標(biāo)記磷酸化蛋白*激酶JAK-2抗體IgG
Anti-JNK1/3 /FITC  熒光素標(biāo)記c-Jun氨基末端激酶1/3抗體IgG
Anti-Jun B/FITC  熒光素標(biāo)記活化蛋白激酶B抗體IgG
Anti-Jun D/FITC  熒光素標(biāo)記活化蛋白激酶D抗體IgG
Anti-p-Klf5/CKLF /FITC  熒光素標(biāo)記磷酸化腸道內(nèi)富含的Kruppel樣因子5抗體IgG

Anti-ISR-α protein/RBITC  羅丹明標(biāo)記胰島素受體-α 抗體IgG
Anti-Integrin-α 4/FITC  熒光素標(biāo)記整合素α4抗體IgG
Anti-Integrin-α V/CD49e /FITC  熒光素標(biāo)記整合素αV抗體IgG
Anti-Integrin αV /FITC  熒光素標(biāo)記巨噬細(xì)胞來源的趨化因子αV抗體IgG
Anti-Integrin-β3/ITG-β3/CD61/FITC  熒光素標(biāo)記整合素-β3抗體IgG
Anti-Iumbrokinase/FITC  熒光素標(biāo)記抗蚯蚓纖溶酶抗體/抗*抗體IgG
Anti-Integrin α6/CD49f/VLA-6/FITC  熒光素標(biāo)記整合素α6抗體IgG
Anti-Jab1/FITC  熒光素標(biāo)記Jun激活區(qū)域-連接蛋白1抗體IgG
Anti-Integrin α2b/CD41b/GPIIb/CD61/FITC  熒光素標(biāo)記血小板膜糖蛋白ⅡbⅢa抗體IgG
Anti-p-Klf5/CKLF /FITC  熒光素標(biāo)記磷酸化腸道內(nèi)富含的Kruppel樣因子5抗體IgG
Anti-phospho-Syndecan 4/FITC  熒光素標(biāo)記抗磷酸化多配體聚糖4抗體IgG
Anti-KGFR/RBITC  紅色羅丹明標(biāo)記角質(zhì)形成細(xì)胞生長因子受體抗體IgG
Anti-KiSS-1R/GPR54/GPCR54/FITC  熒光素標(biāo)記G蛋白偶聯(lián)受體54抗體IgG
Anti-Ki-67/FITC  熒光素標(biāo)記Ki-67 Antigen抗體IgG
Anti-Ki-67/FITC  熒光素標(biāo)記Ki-67 Antigen抗體IgG
Anti-Kif14 protein /FITC  熒光素標(biāo)記驅(qū)動(dòng)蛋白家族Member14蛋白抗體IgG
Anti-Kiss-1/FITC  熒光素標(biāo)記腫瘤轉(zhuǎn)移抑制基因抗體IgG
Anti-Klf4/FITC  熒光素標(biāo)記腸道內(nèi)富含的Kruppel樣因子/上皮鋅指蛋白K抗體IgG

產(chǎn)品介紹：

C9 is a plasma protein synthesized in the liver and monocytes consisting of a single polypeptide chain. C9 is a part of the membrane attack complex （MAC）, an important component of the immune system. The MAC forms upon complement system activation by invading pathogenic bacteria and consists of the four major complement proteins: C5b, C6, C7 and C8. These complement proteins bind to the outer surface of the plasma membrane of the invading cell. C9 binds to the membrane associated C5b-8 protein, which leads to the circular polymerization of 12-18 C9 molecules. These polymerized C9 molecules form a ring structure in the membrane. Molecules can then diffuse freely through this transmembrane channel, causing cell lysis and destruction of the invading bacterial cell.